Melanotan-2 (MT-2) is a synthetic analog of alpha-melanocyte stimulating hormone (alpha-MSH) that activates melanocortin receptors — primarily MC1R — to stimulate melanin production. In the original Phase I clinical trial, just 5 low-dose subcutaneous injections produced measurable pigmentation increases in 2 of 3 subjects (Dorr et al., 1996).
But "measurable" in a lab and "visible tan" in a mirror are different things. Your timeline depends almost entirely on one variable: your Fitzpatrick skin type.
This guide breaks down what to realistically expect at each stage — from first injection through long-term maintenance — based on published clinical data and documented user reports. This is not medical advice. MT-2 has no FDA approval for any indication.
The #1 Variable: Fitzpatrick Skin Type
Before looking at timelines, you need to know your starting point. Fitzpatrick skin type determines your baseline melanocyte density, melanin production capacity, and how visibly your skin responds to MT-2.
| Fitzpatrick Type | Description | MT-2 Response Speed | Typical Loading Duration |
|---|---|---|---|
| I | Always burns, never tans | Slowest — 3-4+ weeks for subtle change | 4-6 weeks |
| II | Burns easily, tans minimally | Slow — 2-3 weeks for noticeable change | 3-4 weeks |
| III | Burns moderately, tans gradually | Moderate — 1-2 weeks for visible darkening | 2-3 weeks |
| IV | Burns minimally, tans easily | Fast — 5-10 days for noticeable results | 2 weeks |
| V-VI | Rarely/never burns, dark baseline | Fastest — but least "dramatic" change | 1-2 weeks |
Type I skin has fewer active melanocytes and produces predominantly pheomelanin (reddish-yellow pigment) rather than eumelanin (brown-black). MT-2 can shift this ratio, but the process takes significantly longer than in skin types that already produce eumelanin efficiently.
Key point: If you are Type I-II, do not compare your progress to Type III-IV reports online. Your biology is fundamentally different.
Week 1-2: Loading Phase — Side Effects Lead, Tanning Follows
The first 1-2 weeks are primarily about side effect management and melanocyte activation. Most users are dosing 250-500mcg daily during this phase. See the Melanotan-2 dosing guide for the full loading protocol.
What to Expect
Days 1-3: Side effects dominate.
- Nausea peaks 30-90 minutes post-injection and typically lasts 2-4 hours. In clinical studies, nausea was the most common adverse event at virtually all MT-2 dose levels (Dorr et al., 1996).
- Facial flushing — a warm, red flush across the face and upper body lasting 1-3 hours.
- Appetite suppression — noticeable from the first dose for most users. MT-2 activates MC4R in the hypothalamus, the same pathway that mediates leptin-driven satiety (Grieco et al., 2010).
- Spontaneous erections and increased libido (in males) — often beginning with the first or second dose. This MC4R-mediated effect led directly to the development of PT-141 (Wessells et al., 2000).
Days 3-7: Side effects begin to diminish. Subtle skin changes start.
- Nausea and flushing decrease noticeably as receptor tolerance develops.
- Freckles and moles may begin to darken — this is often the first visible sign of melanocyte activation.
- Fitzpatrick Type III-IV users may notice a slight overall darkening, particularly on the face and forearms.
- Type I-II users: likely no visible tanning change yet. This is normal.
Days 7-14: First real tanning signal.
- The Phase I clinical trial demonstrated measurable pigmentation increases after just 5 doses given every other day (Dorr et al., 1996). With daily loading doses, most users with Type II+ skin report visible darkening by the end of week 2.
- Darkening is most obvious on the face, neck, forearms, and any UV-exposed areas.
- Areas with minimal UV exposure will lag behind significantly.
Loading Phase Summary
| Marker | Type I-II | Type III-IV | Type V-VI |
|---|---|---|---|
| Freckle/mole darkening | Day 5-10 | Day 3-7 | Day 2-5 |
| Visible facial darkening | Day 10-14+ | Day 5-10 | Day 3-7 |
| Side effects peak | Day 1-3 | Day 1-3 | Day 1-3 |
| Side effects subside | Day 7-10 | Day 5-7 | Day 5-7 |
Weeks 2-4: Visible Tan Development
This is where most users see the results they signed up for. Melanocytes are now actively producing and depositing melanin in the epidermis, and the cumulative effect of daily dosing becomes visually obvious.
What to Expect
Weeks 2-3:
- Face, neck, and arms are noticeably darker. The tan appears most concentrated on areas receiving any UV exposure.
- The color quality shifts from a "dirty" or uneven initial darkening to a more natural-looking bronze tone.
- Uneven tanning is common — areas with more melanocytes (face, shoulders, forearms) darken faster than torso or legs.
- Freckles may become quite pronounced. Existing moles continue to darken. Monitor any mole changes carefully — see the Melanotan-2 side effects guide and get a baseline dermatological screening.
Weeks 3-4:
- Most Type III-IV users have achieved a significant visible tan by this point.
- Type II users are catching up — a noticeable "warm glow" that others will comment on.
- Type I users may have a subtle but real change: a shift from "paper white" to "warm ivory" or light golden tone.
- Appetite suppression may plateau or normalize slightly as MC4R desensitization occurs.
- Sexual side effects remain consistent in most users throughout active dosing.
The UV Multiplier
MT-2 and UV exposure work synergistically. Clinical research on the related compound melanotan-1 demonstrated that melanocortin peptides combined with UV exposure produced significantly enhanced tanning compared to UV alone — and the tan lasted 3+ weeks longer (Levine et al., 2004).
You do not need aggressive UV exposure. Even 10-15 minutes of incidental sun exposure on dosing days dramatically accelerates results. Tanning bed sessions should be brief (5-10 minutes) and infrequent. The goal is activation, not burning.
Without UV exposure, results are markedly reduced. MT-2 primes the melanocytes, but UV provides the trigger signal to produce and distribute melanin into the skin layers.
Months 1-2: Full Tan and Maintenance Transition
By 4-8 weeks of loading, most users have reached or are approaching their desired pigmentation level. This is the transition point from loading to maintenance dosing.
What to Expect
- Full tan established for Type III-IV users (typically by week 4-5). Type I-II users may need the full 6-8 weeks.
- Color stabilization — the tan looks more even and natural as melanin distribution equalizes across skin areas.
- Maintenance transition — loading dose (daily 250-500mcg) shifts to maintenance (500mcg 1-2x per week). Some users maintain on even less frequent dosing.
- Side effects at maintenance are minimal. Nausea is typically absent at this stage. Appetite effects and sexual effects persist but are milder with less frequent dosing.
- Mole monitoring remains critical. A qualitative study of MT-2 users found that mole darkening and new mole formation were among the most commonly reported longer-term effects (Evans-Brown et al., 2021). Schedule a dermatological skin check if you have not already.
Maintenance Dosing Protocol
The goal of maintenance is to sustain melanin levels with the minimum effective dose:
| Skin Type | Typical Maintenance Dose | Frequency |
|---|---|---|
| Type I-II | 500mcg | 2x per week |
| Type III-IV | 250-500mcg | 1-2x per week |
| Type V-VI | 250mcg | 1x per week or less |
With consistent UV exposure (even incidental), many users find they can reduce maintenance frequency over time. Without UV, maintenance doses need to be more frequent to preserve pigmentation.
Months 3+: Long-Term Considerations
Users on long-term MT-2 maintenance report stable tanning results with minimal side effects. However, several long-term considerations deserve attention.
Sustained Effects
- Tan quality improves over months as melanin distribution becomes more uniform.
- Dose requirements may decrease. Many long-term users find they need less frequent maintenance dosing over time.
- Seasonal adjustment — users in northern latitudes with minimal winter UV may need slightly higher maintenance frequency in winter months, or accept some fading.
Safety Monitoring
- Dermatological screening every 3-6 months during active use. At least one case report has documented melanoma emergence during MT-2 use in combination with tanning bed exposure (Reid et al., 2013). While causation was not established, melanocyte stimulation demands ongoing vigilance.
- Track any mole changes using the ABCDE criteria (asymmetry, border, color, diameter, evolving). Photograph moles at baseline for comparison.
- Blood pressure monitoring — MT-2 can cause transient blood pressure elevations. See the Melanotan-2 bloodwork guide for the full monitoring panel.
What Happens When You Stop
- Week 1-2 after stopping: No immediate visible change. Melanin already deposited in the skin remains.
- Weeks 2-4: Gradual fading begins as natural skin cell turnover replaces pigmented cells.
- Weeks 4-8: Most of the MT-2 enhanced tan has faded. Rate depends on skin type and ongoing UV exposure.
- Full return to baseline: 2-3 months for most users, though some report residual pigmentation lasting longer, particularly in freckles.